Product category:
Chromatographs: liquid, ion, gel, HPLC
News Release from: ESA Biosciences | Subject: CoulArray II
Edited by the Laboratorytalk Editorial
Team on 18 August 2006
Electrochemical array measures oxidative
stability
ESA Biosciences reports on a new method using its unique CoulArray II electrochemical detector that enables researchers to perform rapid oxidative stability measurements
A key parameter for the use of any compound as a drug is that of its inherent chemical stability This stability can include everything from a measurement of a compound's stability under oxidative conditions, to the testing of a compound under artificial 'forced degradation' conditions
This article was originally published on Laboratorytalk on 7 Dec 2001 at 8.00am (UK)
Related stories
Multi-dimensional HPLC detector
ESA Analytical says the CoulArray II detector is a revolutionary new instrument that works with your HPLC to provide a 3-dimensional look at your sample
Determining low level impurities in APIs
ESA Biosciences has a new technical poster describing how the Corona Cad enables routine measurement of low-nanogram levels of organic impurities in active pharmaceutical ingredients
Free guide to optimised electrochemical detection
ESA Biosciences has published an informative 14-page guide for laboratories interested in gaining the full sensitivity and selectivity benefits from a HPLC electrochemical detection (ECD) system
The ESA methodology describes using the CoulArray II system to perform a wide variety of single electron oxidation reactions for predicting the oxidative stability of a compound under one or more different conditions.
These assays, which closely mimic the natural oxidative degradation of compounds, can be conducted in only a few seconds per sample.
Determining the relative stability of a compound or a formulation to oxidation has traditionally been a laborious and time-consuming process involving methods such as peroxide oxidation, elevated oxygen tension, or sophisticated forced degradation studies.
Because of the nature of these types of studies, they have typically not been done until later in the drug development process.
The CoulArray II is demonstrated to rapidly screen a large number of compounds for their relative stabilities enabling researchers to utilise this valuable information much earlier in the drug discovery process.
The CoulArray II is an excellent tool for high throughput measurement allowing researchers to gather important information about a compound's inherent stability and make earlier and better decisions about a compound's suitability for development.
This can have a major impact on both synthetic and medicinal chemistry efforts in any pharmaceutical company. Request a free brochure from ESA Biosciences ...
• ESA Biosciences: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
